Inactive Instrument
Synergy Pharmaceuticals Inc Share Price Nasdaq
Stocks
US8716393082
Biotechnology & Medical Research
| 1 day | -52.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Leslie M. Magnus
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2015 |
Stephen Comiskey
PRN | Corporate Officer/Principal | - | 15/07/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -52.00% | -62.59% | - | - | 0 | |
| -2.11% | -1.68% | +43.40% | +95.27% | 6.69TCr | |
| -0.23% | -4.45% | +32.50% | +75.75% | 6.2TCr | |
| +1.67% | +2.47% | -11.32% | +380.54% | 2.83TCr | |
| -1.05% | -4.43% | +28.84% | +10.59% | 2.46TCr | |
| +0.34% | -6.78% | -0.01% | -16.35% | 2.43TCr | |
| +0.43% | -3.37% | +16.22% | -17.99% | 1.94TCr | |
| -3.03% | -2.29% | +181.72% | +335.27% | 1.68TCr | |
| -1.94% | -4.94% | -8.15% | +483.69% | 1.42TCr | |
| +3.24% | -0.31% | -7.34% | +880.45% | 1.4TCr | |
| Average | -5.47% | -2.95% | +30.65% | +247.47% | 3TCr | |
| Weighted average by Cap. | -0.56% | -2.83% | +31.25% | +170.65% |
Employees
-
